- Tunisia has become the first country in the WHO Eastern Mediterranean Region to eradicate trachoma nationwide.
- Elimination of trachoma was validated by the World Health Organization in June 2023.
- Less than 0.1% of children aged one to nine in Tunisia show signs of active trachoma infection.
- Tunisia’s success in eradicating trachoma was the result of over half a century of persistent effort and scientific rigor.
- Elimination of trachoma has broken the cycle of blindness and fear in Tunisia’s communities.
In the sun-baked villages nestled along Tunisia’s arid southern frontier, generations once lived under the shadow of a silent thief: trachoma. The bacterial infection, passed through contact with eye and nose discharges, crept from child to child, flaring in recurrent bouts that scarred the inner eyelid, turned lashes inward, and eventually scraped the cornea raw. By adulthood, many faced irreversible blindness. But today, those same communities stand free of that fear. No longer must mothers shield their children from shared towels or dusty courtyards with dread. The relentless cycle has been broken. In a quiet triumph of public health, Tunisia has officially eliminated trachoma as a public health problem — a milestone validated in 2023 by the World Health Organization, capping over half a century of persistent effort, scientific rigor, and grassroots determination.
Tunisia’s Public Health Victory Confirmed
The World Health Organization’s formal validation in June 2023 marked Tunisia as the first country in the WHO Eastern Mediterranean Region to eliminate trachoma nationwide. This designation means that less than 0.1% of children aged one to nine show signs of active trachoma infection, and fewer than 0.2% of adults exhibit trachomatous trichiasis — the late-stage condition where eyelashes turn inward and scratch the cornea. These criteria, set by the WHO, confirm that the disease no longer poses a significant threat to public health. Tunisia’s success was achieved through widespread implementation of the SAFE strategy — Surgery for trichiasis, Antibiotics to clear infection, Facial cleanliness, and Environmental improvements to reduce transmission. Repeated surveys across at-risk regions consistently showed infection rates well below the elimination threshold, allowing national authorities to apply for validation in 2022.
The Long Road to Elimination
Trachoma was once endemic in rural and marginalized areas of Tunisia, particularly in the south and central regions where water scarcity and poor sanitation created ideal conditions for transmission. The fight began in earnest in the 1970s, when the Ministry of Health launched mass antibiotic campaigns and improved access to clean water. In the 1990s, Tunisia integrated the WHO-recommended SAFE strategy into its national trachoma program, scaling up eyelid surgery for advanced cases and launching hygiene education in schools. By the early 2000s, infection rates had plummeted, but health officials maintained surveillance to prevent resurgence. Sustained political commitment, cross-sectoral collaboration with water and education ministries, and integration of trachoma services into primary healthcare systems were critical. The country’s relatively small size and centralized health infrastructure allowed for efficient monitoring and rapid response — advantages not easily replicated in larger, less stable nations.
Champions of Change in Public Health
The elimination of trachoma in Tunisia was driven by a coalition of epidemiologists, ophthalmologists, community health workers, and government leaders who viewed blindness prevention as both a medical and moral imperative. Dr. Amel Ben Alaya, a leading ophthalmologist involved in the national program, emphasized that success hinged on trust: “We didn’t just deliver antibiotics — we listened to communities, trained local health agents, and made facial cleanliness part of daily life.” Frontline workers, often women from the villages themselves, played a crucial role in identifying cases, encouraging surgery, and teaching children to wash their faces daily. At the policy level, Tunisia’s Ministry of Health maintained consistent funding and prioritized equity, ensuring that remote populations received the same care as urban centers. International partners, including the WHO and the International Trachoma Initiative, provided technical guidance and donated azithromycin, but the strategy and execution remained firmly Tunisian.
What This Means for Global Health
Tunisia’s achievement offers a blueprint for other endemic countries, demonstrating that trachoma elimination is possible even in resource-limited settings with sustained political will. For the estimated 125 million people still at risk worldwide — primarily across sub-Saharan Africa, Yemen, and parts of South Asia — Tunisia’s model underscores the importance of integrated, community-led approaches. The validation also strengthens regional momentum; neighboring Algeria and Morocco are nearing elimination status, and the African Union has set a 2030 target for continent-wide eradication. However, vigilance remains essential. As climate change and migration patterns shift disease dynamics, Tunisia must maintain surveillance to detect any resurgence. The infrastructure built for trachoma control — from lab networks to community health cadres — now supports broader eye health and infectious disease programs.
The Bigger Picture
Tunisia’s victory over trachoma transcends the realm of disease control; it is a testament to what organized, long-term public health investment can achieve. In an era often dominated by emergency responses to pandemics and conflicts, this quiet success reminds us that prevention, education, and equity are the cornerstones of resilient health systems. It also challenges the assumption that neglected tropical diseases are intractable in low- and middle-income countries. By treating trachoma not as an isolated issue but as a symptom of broader social inequities — lack of clean water, poor hygiene, and limited healthcare access — Tunisia addressed root causes rather than symptoms.
As the global health community celebrates this milestone, the focus now shifts to sustaining gains and supporting other nations on the same path. Tunisia’s journey proves that with leadership, community engagement, and unwavering commitment, even the most entrenched diseases can be consigned to history books. The silence of trachoma in Tunisia is not just the absence of infection — it is the sound of progress, heard in the laughter of children who will never know blindness from a preventable cause.
Source: WHO